SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : A BIOTECHNOLOGY STOCK WITH A FUTURE - GENETIC VECTORS
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (6)10/13/1997 1:37:00 PM
From: Jim Drewitz   of 52
 
"O"

In simple terms,currently GVEC creates and makes tests for drug manufacturers. The big guys. Drug makers produce many drugs using living cells...for example:insulin. How many million diabetics take insulin every day? Drug Mfgrs using GVEC's EpiDNA Picogram Assay can detect DNA contaminatin down to one picogram per dose. The FDA recommends that drug mfgrs monitor the content of DNA in therapeutic products to ensure the level does not exceed 10 picograms per injected dose. You can see how GVEC test far exceed government standards. GVEC's test is faster,(2.5 hrs.) more accurate and more cost effective than other test products currently available.

Market share is very small, but growing. Management is dedicated to increasing sales and revenues...and has sales folks making presentations every week.

Stock is sitting around $10 with little volume. We need to introduce the Company to more investors...and to the street.

Hope this helps. Keep the string going.

Jim Drewitz
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News